Europe Pharmerging Market Report 2017

March 2017 | 114 pages | ID: EE195D0D021EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Pharmerging

Revenue, means the sales value of Pharmerging

This report studies sales (consumption) of Pharmerging in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

• AstraZeneca
• GlaxoSmithKline
• Pfizer
• Sanofi
• Novartis
• Abbott Laboratories
• Shire
• Bayer
• Biogen
• F. Hoffmann-La Roche
• Johnson & Johnson
• Mitsubishi Tanabe Pharma
• Novo Nordisk
• Sun Pharmaceutical
• Takeda Pharma
• Teva Pharmaceutical Industries

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Pharmerging in these countries, from 2011 to 2021 (forecast), like

• Germany
• France
• UK
• Russia
• Italy
• Spain
• Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Tier 1
• Tier 2
• Tier 3

Split by application, this report focuses on sales, market share and growth rate of Pharmerging in each application, can be divided into

• Lung Cancer
• Breast Cancer
• Chronic Myeloid Leukemia
• Lymphomas
• Other

Contents

Europe Pharmerging Market Report 2017

1 PHARMERGING OVERVIEW

1.1 Product Overview and Scope of Pharmerging
1.2 Classification of Pharmerging
  1.2.1 Tier
  1.2.2 Tier
  1.2.3 Tier
1.3 Application of Pharmerging
  1.3.1 Lung Cancer
  1.3.2 Breast Cancer
  1.3.3 Chronic Myeloid Leukemia
  1.3.4 Lymphomas
  1.3.5 Other
1.4 Pharmerging Market by Countries
  1.4.1 Germany Status and Prospect (2012-2022)
  1.4.2 France Status and Prospect (2012-2022)
  1.4.3 UK Status and Prospect (2012-2022)
  1.4.4 Russia Status and Prospect (2012-2022)
  1.4.5 Italy Status and Prospect (2012-2022)
  1.4.6 Spain Status and Prospect (2012-2022)
  1.4.7 Benelux Status and Prospect (2012-2022)
1.5 Europe Market Size (Value and Volume) of Pharmerging (2012-2022)
  1.5.1 Europe Pharmerging Sales and Growth Rate (2012-2022)
  1.5.2 Europe Pharmerging Revenue and Growth Rate (2012-2022)

2 EUROPE PHARMERGING BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Europe Pharmerging Market Competition by Manufacturers
  2.1.1 Europe Pharmerging Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Europe Pharmerging Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Pharmerging (Volume and Value) by Type
  2.2.1 Europe Pharmerging Sales and Market Share by Type (2012-2017)
  2.2.2 Europe Pharmerging Revenue and Market Share by Type (2012-2017)
2.3 Europe Pharmerging (Volume and Value) by Countries
  2.3.1 Europe Pharmerging Sales and Market Share by Countries (2012-2017)
  2.3.2 Europe Pharmerging Revenue and Market Share by Countries (2012-2017)
2.4 Europe Pharmerging (Volume) by Application

3 GERMANY PHARMERGING (VOLUME, VALUE AND SALES PRICE)

3.1 Germany Pharmerging Sales and Value (2012-2017)
  3.1.1 Germany Pharmerging Sales and Growth Rate (2012-2017)
  3.1.2 Germany Pharmerging Revenue and Growth Rate (2012-2017)
  3.1.3 Germany Pharmerging Sales Price Trend (2012-2017)
3.2 Germany Pharmerging Sales and Market Share by Manufacturers
3.3 Germany Pharmerging Sales and Market Share by Type
3.4 Germany Pharmerging Sales and Market Share by Application

4 FRANCE PHARMERGING (VOLUME, VALUE AND SALES PRICE)

4.1 France Pharmerging Sales and Value (2012-2017)
  4.1.1 France Pharmerging Sales and Growth Rate (2012-2017)
  4.1.2 France Pharmerging Revenue and Growth Rate (2012-2017)
  4.1.4 France Pharmerging Sales Price Trend (2012-2017)
4.2 France Pharmerging Sales and Market Share by Manufacturers
4.3 France Pharmerging Sales and Market Share by Type
4.4 France Pharmerging Sales and Market Share by Application

5 UK PHARMERGING (VOLUME, VALUE AND SALES PRICE)

5.1 UK Pharmerging Sales and Value (2012-2017)
  5.1.1 UK Pharmerging Sales and Growth Rate (2012-2017)
  5.1.2 UK Pharmerging Revenue and Growth Rate (2012-2017)
  5.1.5 UK Pharmerging Sales Price Trend (2012-2017)
5.2 UK Pharmerging Sales and Market Share by Manufacturers
5.3 UK Pharmerging Sales and Market Share by Type
5.4 UK Pharmerging Sales and Market Share by Application

6 RUSSIA PHARMERGING (VOLUME, VALUE AND SALES PRICE)

6.1 Russia Pharmerging Sales and Value (2012-2017)
  6.1.1 Russia Pharmerging Sales and Growth Rate (2012-2017)
  6.1.2 Russia Pharmerging Revenue and Growth Rate (2012-2017)
  6.1.6 Russia Pharmerging Sales Price Trend (2012-2017)
6.2 Russia Pharmerging Sales and Market Share by Manufacturers
6.3 Russia Pharmerging Sales and Market Share by Type
6.4 Russia Pharmerging Sales and Market Share by Application

7 ITALY PHARMERGING (VOLUME, VALUE AND SALES PRICE)

7.1 Italy Pharmerging Sales and Value (2012-2017)
  7.1.1 Italy Pharmerging Sales and Growth Rate (2012-2017)
  7.1.2 Italy Pharmerging Revenue and Growth Rate (2012-2017)
  7.1.7 Italy Pharmerging Sales Price Trend (2012-2017)
7.2 Italy Pharmerging Sales and Market Share by Manufacturers
7.3 Italy Pharmerging Sales and Market Share by Type
7.4 Italy Pharmerging Sales and Market Share by Application

8 SPAIN PHARMERGING (VOLUME, VALUE AND SALES PRICE)

8.1 Spain Pharmerging Sales and Value (2012-2017)
  8.1.1 Spain Pharmerging Sales and Growth Rate (2012-2017)
  8.1.2 Spain Pharmerging Revenue and Growth Rate (2012-2017)
  8.1.8 Spain Pharmerging Sales Price Trend (2012-2017)
8.2 Spain Pharmerging Sales and Market Share by Manufacturers
8.3 Spain Pharmerging Sales and Market Share by Type
8.4 Spain Pharmerging Sales and Market Share by Application

9 BENELUX PHARMERGING (VOLUME, VALUE AND SALES PRICE)

9.1 Benelux Pharmerging Sales and Value (2012-2017)
  9.1.1 Benelux Pharmerging Sales and Growth Rate (2012-2017)
  9.1.2 Benelux Pharmerging Revenue and Growth Rate (2012-2017)
  9.1.9 Benelux Pharmerging Sales Price Trend (2012-2017)
9.2 Benelux Pharmerging Sales and Market Share by Manufacturers
9.3 Benelux Pharmerging Sales and Market Share by Type
9.4 Benelux Pharmerging Sales and Market Share by Application

10 EUROPE PHARMERGING MANUFACTURERS ANALYSIS

10.1 AstraZeneca
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Pharmerging Product Type, Application and Specification
    10.1.2.1 Product A
    10.1.2.2 Product B
  10.1.3 AstraZeneca Pharmerging Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Main Business/Business Overview
10.2 GlaxoSmithKline
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Pharmerging Product Type, Application and Specification
    10.2.2.1 Product A
    10.2.2.2 Product B
  10.2.3 GlaxoSmithKline Pharmerging Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Main Business/Business Overview
10.3 Pfizer
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Pharmerging Product Type, Application and Specification
    10.3.2.1 Product A
    10.3.2.2 Product B
  10.3.3 Pfizer Pharmerging Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Main Business/Business Overview
10.4 Sanofi
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Pharmerging Product Type, Application and Specification
    10.4.2.1 Product A
    10.4.2.2 Product B
  10.4.3 Sanofi Pharmerging Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Main Business/Business Overview
10.5 Novartis
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Pharmerging Product Type, Application and Specification
    10.5.2.1 Product A
    10.5.2.2 Product B
  10.5.3 Novartis Pharmerging Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Main Business/Business Overview
10.6 Abbott Laboratories
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Pharmerging Product Type, Application and Specification
    10.6.2.1 Product A
    10.6.2.2 Product B
  10.6.3 Abbott Laboratories Pharmerging Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Main Business/Business Overview
10.7 Shire
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Pharmerging Product Type, Application and Specification
    10.7.2.1 Product A
    10.7.2.2 Product B
  10.7.3 Shire Pharmerging Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Main Business/Business Overview
10.8 Bayer
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Pharmerging Product Type, Application and Specification
    10.8.2.1 Product A
    10.8.2.2 Product B
  10.8.3 Bayer Pharmerging Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Main Business/Business Overview
10.9 Biogen
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Pharmerging Product Type, Application and Specification
    10.9.2.1 Product A
    10.9.2.2 Product B
  10.9.3 Biogen Pharmerging Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Main Business/Business Overview
10.10 F. Hoffmann-La Roche
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Pharmerging Product Type, Application and Specification
    10.10.2.1 Product A
    10.10.2.2 Product B
  10.10.3 F. Hoffmann-La Roche Pharmerging Sales, Revenue, Price and Gross Margin (2012-2017)
  10.10.4 Main Business/Business Overview
10.11 Johnson & Johnson
10.12 Mitsubishi Tanabe Pharma
10.13 Novo Nordisk
10.14 Sun Pharmaceutical
10.15 Takeda Pharma
10.16 Teva Pharmaceutical Industries

11 PHARMERGING MANUFACTURING COST ANALYSIS

11.1 Pharmerging Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Pharmerging

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Pharmerging Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Pharmerging Major Manufacturers in 2015
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 EUROPE PHARMERGING MARKET FORECAST (2017-2022)

14.1 Germany Pharmerging Sales Forecast (2017-2022)
14.2 France Pharmerging Sales Forecast (2017-2022)
14.3 UK Pharmerging Sales Forecast (2017-2022)
14.4 Russia Pharmerging Sales Forecast (2017-2022)
14.5 Italy Pharmerging Sales Forecast (2017-2022)
14.6 Spain Pharmerging Sales Forecast (2017-2022)
14.7 Benelux Pharmerging Sales Forecast (2017-2022)
14.8 Europe Pharmerging Sales Forecast by Type (2017-2022)
14.9 Europe Pharmerging Sales Forecast by Application (2017-2022)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Pharmerging
Table Classification of Pharmerging
Figure Europe Sales Market Share of Pharmerging by Type in 2015
Figure Tier 1 Picture
Figure Tier 2 Picture
Figure Tier 3 Picture
Table Application of Pharmerging
Figure Europe Sales Market Share of Pharmerging by Application in 2015
Figure Lung Cancer Examples
Figure Breast Cancer Examples
Figure Chronic Myeloid Leukemia Examples
Figure Lymphomas Examples
Figure Other Examples
Figure Germany Pharmerging Revenue and Growth Rate (2012-2022)
Figure France Pharmerging Revenue and Growth Rate (2012-2022)
Figure UK Pharmerging Revenue and Growth Rate (2012-2022)
Figure Russia Pharmerging Revenue and Growth Rate (2012-2022)
Figure Italy Pharmerging Revenue and Growth Rate (2012-2022)
Figure Spain Pharmerging Revenue and Growth Rate (2012-2022)
Figure Benelux Pharmerging Revenue and Growth Rate (2012-2022)
Figure Europe Pharmerging Sales and Growth Rate (2012-2022)
Figure Europe Pharmerging Revenue and Growth Rate (2012-2022)
Table Europe Pharmerging Sales of Key Manufacturers (2015 and 2016)
Table Europe Pharmerging Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Pharmerging Sales Share by Manufacturers
Figure 2016 Pharmerging Sales Share by Manufacturers
Table Europe Pharmerging Revenue by Manufacturers (2015 and 2016)
Table Europe Pharmerging Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Pharmerging Revenue Share by Manufacturers
Table 2016 Europe Pharmerging Revenue Share by Manufacturers
Table Europe Pharmerging Sales and Market Share by Type (2012-2017)
Table Europe Pharmerging Sales Share by Type (2012-2017)
Figure Sales Market Share of Pharmerging by Type (2012-2017)
Figure Europe Pharmerging Sales Growth Rate by Type (2012-2017)
Table Europe Pharmerging Revenue and Market Share by Type (2012-2017)
Table Europe Pharmerging Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Pharmerging by Type (2012-2017)
Figure Europe Pharmerging Revenue Growth Rate by Type (2012-2017)
Table Europe Pharmerging Sales and Market Share by Countries (2012-2017)
Table Europe Pharmerging Sales Share by Countries (2012-2017)
Figure Sales Market Share of Pharmerging by Countries (2012-2017)
Table Europe Pharmerging Revenue and Market Share by Countries (2012-2017)
Table Europe Pharmerging Revenue Share by Countries (2012-2017)
Figure Revenue Market Share of Pharmerging by Countries (2012-2017)
Table Europe Pharmerging Sales and Market Share by Application (2012-2017)
Table Europe Pharmerging Sales Share by Application (2012-2017)
Figure Sales Market Share of Pharmerging by Application (2012-2017)
Figure Germany Pharmerging Sales and Growth Rate (2012-2017)
Figure Germany Pharmerging Revenue and Growth Rate (2012-2017)
Figure Germany Pharmerging Sales Price Trend (2012-2017)
Table Germany Pharmerging Sales by Manufacturers (2015 and 2016)
Table Germany Pharmerging Market Share by Manufacturers (2015 and 2016)
Table Germany Pharmerging Sales by Type (2015 and 2016)
Table Germany Pharmerging Market Share by Type (2015 and 2016)
Table Germany Pharmerging Sales by Application (2015 and 2016)
Table Germany Pharmerging Market Share by Application (2015 and 2016)
Figure France Pharmerging Sales and Growth Rate (2012-2017)
Figure France Pharmerging Revenue and Growth Rate (2012-2017)
Figure France Pharmerging Sales Price Trend (2012-2017)
Table France Pharmerging Sales by Manufacturers (2015 and 2016)
Table France Pharmerging Market Share by Manufacturers (2015 and 2016)
Table France Pharmerging Sales by Type (2015 and 2016)
Table France Pharmerging Market Share by Type (2015 and 2016)
Table France Pharmerging Sales by Application (2015 and 2016)
Table France Pharmerging Market Share by Application (2015 and 2016)
Figure UK Pharmerging Sales and Growth Rate (2012-2017)
Figure UK Pharmerging Revenue and Growth Rate (2012-2017)
Figure UK Pharmerging Sales Price Trend (2012-2017)
Table UK Pharmerging Sales by Manufacturers (2015 and 2016)
Table UK Pharmerging Market Share by Manufacturers (2015 and 2016)
Table UK Pharmerging Sales by Type (2015 and 2016)
Table UK Pharmerging Market Share by Type (2015 and 2016)
Table UK Pharmerging Sales by Application (2015 and 2016)
Table UK Pharmerging Market Share by Application (2015 and 2016)
Figure Russia Pharmerging Sales and Growth Rate (2012-2017)
Figure Russia Pharmerging Revenue and Growth Rate (2012-2017)
Figure Russia Pharmerging Sales Price Trend (2012-2017)
Table Russia Pharmerging Sales by Manufacturers (2015 and 2016)
Table Russia Pharmerging Market Share by Manufacturers (2015 and 2016)
Table Russia Pharmerging Sales by Type (2015 and 2016)
Table Russia Pharmerging Market Share by Type (2015 and 2016)
Table Russia Pharmerging Sales by Application (2015 and 2016)
Table Russia Pharmerging Market Share by Application (2015 and 2016)
Figure Italy Pharmerging Sales and Growth Rate (2012-2017)
Figure Italy Pharmerging Revenue and Growth Rate (2012-2017)
Figure Italy Pharmerging Sales Price Trend (2012-2017)
Table Italy Pharmerging Sales by Manufacturers (2015 and 2016)
Table Italy Pharmerging Market Share by Manufacturers (2015 and 2016)
Table Italy Pharmerging Sales by Type (2015 and 2016)
Table Italy Pharmerging Market Share by Type (2015 and 2016)
Table Italy Pharmerging Sales by Application (2015 and 2016)
Table Italy Pharmerging Market Share by Application (2015 and 2016)
Figure Spain Pharmerging Sales and Growth Rate (2012-2017)
Figure Spain Pharmerging Revenue and Growth Rate (2012-2017)
Figure Spain Pharmerging Sales Price Trend (2012-2017)
Table Spain Pharmerging Sales by Manufacturers (2015 and 2016)
Table Spain Pharmerging Market Share by Manufacturers (2015 and 2016)
Table Spain Pharmerging Sales by Type (2015 and 2016)
Table Spain Pharmerging Market Share by Type (2015 and 2016)
Table Spain Pharmerging Sales by Application (2015 and 2016)
Table Spain Pharmerging Market Share by Application (2015 and 2016)
Figure Benelux Pharmerging Sales and Growth Rate (2012-2017)
Figure Benelux Pharmerging Revenue and Growth Rate (2012-2017)
Figure Benelux Pharmerging Sales Price Trend (2012-2017)
Table Benelux Pharmerging Sales by Manufacturers (2015 and 2016)
Table Benelux Pharmerging Market Share by Manufacturers (2015 and 2016)
Table Benelux Pharmerging Sales by Type (2015 and 2016)
Table Benelux Pharmerging Market Share by Type (2015 and 2016)
Table Benelux Pharmerging Sales by Application (2015 and 2016)
Table Benelux Pharmerging Market Share by Application (2015 and 2016)
Table Pharmerging Basic Information List
Table AstraZeneca Pharmerging Sales, Revenue, Price and Gross Margin (2012-2017)
Figure AstraZeneca Pharmerging Sales Market Share (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Pharmerging Sales, Revenue, Price and Gross Margin (2012-2017)
Table GlaxoSmithKline Pharmerging Sales Market Share (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Pharmerging Sales, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Pharmerging Sales Market Share (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Pharmerging Sales, Revenue, Price and Gross Margin (2012-2017)
Table Sanofi Pharmerging Sales Market Share (2012-2017)
Table Novartis Basic Information List
Table Novartis Pharmerging Sales, Revenue, Price and Gross Margin (2012-2017)
Table Novartis Pharmerging Sales Market Share (2012-2017)
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories Pharmerging Sales, Revenue, Price and Gross Margin (2012-2017)
Table Abbott Laboratories Pharmerging Sales Market Share (2012-2017)
Table Shire Basic Information List
Table Shire Pharmerging Sales, Revenue, Price and Gross Margin (2012-2017)
Table Shire Pharmerging Sales Market Share (2012-2017)
Table Bayer Basic Information List
Table Bayer Pharmerging Sales, Revenue, Price and Gross Margin (2012-2017)
Table Bayer Pharmerging Sales Market Share (2012-2017)
Table Biogen Basic Information List
Table Biogen Pharmerging Sales, Revenue, Price and Gross Margin (2012-2017)
Table Biogen Pharmerging Sales Market Share (2012-2017)
Table F. Hoffmann-La Roche Basic Information List
Table F. Hoffmann-La Roche Pharmerging Sales, Revenue, Price and Gross Margin (2012-2017)
Table F. Hoffmann-La Roche Pharmerging Sales Market Share (2012-2017)
Table Johnson & Johnson Basic Information List
Table Mitsubishi Tanabe Pharma Basic Information List
Table Novo Nordisk Basic Information List
Table Sun Pharmaceutical Basic Information List
Table Takeda Pharma Basic Information List
Table Teva Pharmaceutical Industries Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Pharmerging
Figure Manufacturing Process Analysis of Pharmerging
Figure Pharmerging Industrial Chain Analysis
Table Raw Materials Sources of Pharmerging Major Manufacturers in 2015
Table Major Buyers of Pharmerging
Table Distributors/Traders List
Figure Germany Pharmerging Sales and Growth Rate Forecast (2017-2022)
Figure Germany Pharmerging Revenue and Growth Rate Forecast (2017-2022)
Figure France Pharmerging Sales and Growth Rate Forecast (2017-2022)
Figure France Pharmerging Revenue and Growth Rate Forecast (2017-2022)
Figure UK Pharmerging Sales and Growth Rate Forecast (2017-2022)
Figure UK Pharmerging Revenue and Growth Rate Forecast (2017-2022)
Figure Russia Pharmerging Sales and Growth Rate Forecast (2017-2022)
Figure Russia Pharmerging Revenue and Growth Rate Forecast (2017-2022)
Figure Italy Pharmerging Sales and Growth Rate Forecast (2017-2022)
Figure Italy Pharmerging Revenue and Growth Rate Forecast (2017-2022)
Figure Spain Pharmerging Sales and Growth Rate Forecast (2017-2022)
Figure Spain Pharmerging Revenue and Growth Rate Forecast (2017-2022)
Figure Benelux Pharmerging Sales and Growth Rate Forecast (2017-2022)
Figure Benelux Pharmerging Revenue and Growth Rate Forecast (2017-2022)
Table Europe Pharmerging Sales Forecast by Type (2017-2022)
Table Europe Pharmerging Sales Forecast by Application (2017-2022)